Citorreduction with Chemotherapy

Summar: Until recently, cancer in the peritoneal surface was associated with a poor prognosis. This extreme form of presentation of some tumors of peritoneal, digestive or gynecological origin, that are spread by transcelómica, had therapies only palliative. Currently some patients with peritoneal c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alvarado, S., Feriozzi, G., Giménez, I., Peralta, M., Ramírez, A.
Formato: Artículo revista
Lenguaje:Español
Publicado: Sanatorio Allende. Departamento de enfermería 2018
Materias:
Acceso en línea:https://revistas.unc.edu.ar/index.php/notasenf/article/view/21675
Aporte de:
Descripción
Sumario:Summar: Until recently, cancer in the peritoneal surface was associated with a poor prognosis. This extreme form of presentation of some tumors of peritoneal, digestive or gynecological origin, that are spread by transcelómica, had therapies only palliative. Currently some patients with peritoneal cancer dissemination can benefit from a treatment that combines cytoreduction surgery and intraperitoneal chemotherapy to provide a therapeutic alternative that can improve the survival time and quality of life of these individuals. This work tries to show the development and purposes of a challenging surgery in regards to our role as instrumentators, the cytorreduccion. It consists in the resection of all macroscopic disease, which is visible to the human eye without the aid of a microscope, and then the elimination of microscopic disease by the intraperitoneal use of chemotherapeutic drugs at high temperature. At present the Allende Sanatorio is the only health center in the province of Cordoba and one of the few in the country, which has a program of these characteristics.